Myomo (MYO) Gross Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 114.00 |
| Jun 30, 2025 | -452.00 |
| Mar 31, 2025 | -416.00 |
| Dec 31, 2024 | -405.00 |
| Sep 30, 2024 | 462.00 |
| Jun 30, 2024 | 957.00 |
| Mar 31, 2024 | -404.00 |
| Dec 31, 2023 | -341.00 |
| Sep 30, 2023 | -316.00 |
| Jun 30, 2023 | 490.00 |
| Mar 31, 2023 | 194.00 |
| Dec 31, 2022 | -144.00 |
| Sep 30, 2022 | 116.00 |
| Jun 30, 2022 | -134.00 |
| Mar 31, 2022 | -1,082.00 |
| Dec 31, 2021 | 277.00 |
| Sep 30, 2021 | 372.00 |
| Jun 30, 2021 | -237.00 |
| Mar 31, 2021 | -9.00 |
| Dec 31, 2020 | 1,781.00 |
| Sep 30, 2020 | 439.00 |
| Jun 30, 2020 | -1,718.00 |
| Mar 31, 2020 | -368.00 |
| Dec 31, 2019 | 2,635.00 |
| Sep 30, 2019 | -1,110.00 |
| Jun 30, 2019 | -862.00 |
| Mar 31, 2019 | -913.00 |
| Dec 31, 2018 | 636.00 |
| Sep 30, 2018 | -9.00 |
| Jun 30, 2018 | 281.00 |
| Mar 31, 2018 | -37,686.00 |
| Dec 31, 2017 | 36,775.00 |
| Sep 30, 2017 | 676.00 |
| Jun 30, 2017 | -67,628.00 |
| Mar 31, 2017 | 66,551.00 |
| Dec 31, 2016 | 2,046.00 |
| Sep 30, 2016 | -2,210.00 |